MPI-CDG with transient hypoglycosylation and antithrombin deficiency
Sign Up to like & getrecommendations! Published in 2018 at "Haematologica"
DOI: 10.3324/haematol.2018.211326
Abstract: Antithrombin deficiency is a strong risk factor for venous thromboembolism (VTE) whose testing has demonstrated usefulness.[1][1]–[5][2] Most cases of antithrombin deficiency are explained by mutations in SERPINC1 , the gene encoding this anticoagulant, with detection… read more here.
Keywords: transient hypoglycosylation; mpi cdg; hypoglycosylation antithrombin; antithrombin deficiency ... See more keywords